Jun Ma

Prof. Jun Ma


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2015 in Oncology Reports
Verified
Journal Article
Closed access
CLChangsen Leng
Changsen Leng
YLYin Li
Yin Li
JQJianjun Qin
Jianjun Qin
JMJun Ma
Jun Ma
XLXianben Liu
Xianben Liu
QWQiuming Wang
Qiuming Wang
Spandidos Publications is a scientific publisher with a long-standing international reputation for excellent standards and high quality science publications

1 August 2021 in Developmental Cell
Verified
Journal Article
Closed access
NMNolan K. Maier
Nolan K. Maier
JMJun Ma
Jun Ma
MLMichael A. Lampson
Michael A. Lampson
ICIain M. Cheeseman
Iain M. Cheeseman

2 April 2015 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
ZZZhongmian Zhang
Zhongmian Zhang
PLPing Liu
Ping Liu
JWJian Wang
Jian Wang
TGTianxiao Gong
Tianxiao Gong
FZFang Zhang
Fang Zhang
NHNa Han
Na Han

11 July 2014 in Oncology Reports
Verified
Journal Article
Open access
PDF file
HLHaomiao Li
Haomiao Li
FMFanyu Meng
Fanyu Meng
JMJun Ma
Jun Ma
YYYongkui Yu
Yongkui Yu
XHXionghuai Hua
Xionghuai Hua
YLYin Li
Yin Li
Esophageal squamous cell carcinoma (ESCC) is a common histologic subtype in China. It has been suggested that abnormal expression of microRNAs (miRNAs) is associated with carcinogenesis. We investigated miR-126 expression and its potential targets in ESCC. The expression of miR-126 was detected in cancerous and paired paracancer tissues from 102 patients with ESCC. Target analysis of miR-126 was predicted using online tools. The effect of miR-126 expression on target proteins was assessed using miR-126 mimics or miR-126 inhibitors in ESCC cell lines. In addition, the impact of miR-126 on cell proliferation, apoptosis, migration and invasion was detected in ESCC cell lines. The expression of miR-126 was significantly lower in ESCC tissues, which was associated with tumor differentiation, lymph node metastasis, tumor in-depth and TNM stage. Insulin receptor substrate-1 (IRS-1) and Golgi phosphoprotein 3 (GOLPH3) were overexpressed in ESCC. Overexpression of IRS-1 was associated with cell differentiation, whereas GOLPH3 was related to lymph node metastasis, tumor invasion in-depth and TNM stage in ESCC patients. miR-126 mimics downregulated the expression of IRS-1 and GOLPH3 protein and suppressed the proliferation, migration and invasion of ESCC cells, whereas miR-126 inhibitors led to the opposite results. miR-126 suppressed the proliferation, migration and invasion of ESCC cells, and acted as a tumor suppressor in the carcinogenesis of ESCC. IRS-1 and GOLPH3 are downstream targets of miR-126 at the post-transcriptional level in ESCC.

31 December 2014 in Tissue Barriers
Verified
Journal Article
Closed access
YZYongguo Zhang
Yongguo Zhang
SWShaoping Wu
Shaoping Wu
JMJun Ma
Jun Ma
YXYinglin Xia
Yinglin Xia
XAXun Ai
Xun Ai
JSJun Sun
Jun Sun
The Salmonella type III secretory system secretes virulence proteins, called effectors. Effectors are responsible for the alteration of tight junctions (TJ) and epithelial functions in intestinal infection and inflammation. In a previous study, we have demonstrated that a bacterial effector AvrA plays a role in stabilizing TJs and balancing the opposing action of other bacterial effectors. However, the molecular mechanisms by which AvrA-modulates TJ protein expression remain unknown. AvrA possesses acetyltransferase activity toward specific mitogen-activated protein kinase kinases (MAPKKs) and potently inhibits the c-Jun N-terminal kinase (JNK) pathway in inflammation. Inhibition of the JNK pathway is known to inhibit the TJ protein disassemble. Therefore, we hypothesize that AvrA stabilizes intestinal epithelial TJs via c-Jun and JNK pathway blockage. Using both in vitro and in vivo models, we showed that AvrA targets the c-Jun and JNK pathway that in turn stabilizes TJ protein ZO-1. Inhibition of JNK abolished the effect of AvrA on ZO-1. We further determined that AvrA suppressed the transcription factor activator protein-1, which was regulated by activated JNK. Moreover, we identified the functional domain of AvrA that directly regulated TJs using a series of AvrA mutants. The role of AvrA represents a highly refined bacterial strategy that helps the bacteria survive in the host and dampens the inflammatory response of the host. Our findings have uncovered a novel role of the bacterial protein AvrA in suppressing the inflammatory response of the host through JNK-regulated blockage of epithelial cell barrier function.

1 January 2010 in Marine and Freshwater Behaviour and Physiology
Verified
Journal Article
Closed access
Haihui YeHaihui Ye
Haihui Ye
PSPing Song
Ping Song
JMJun Ma
Jun Ma
HHHuiyang Huang
Huiyang Huang
GWGuizhong Wang
Guizhong Wang
Vertebrate-type steroids, such as progesterone, have been identified in crustaceans. The physiological activity of progesterone during vitellogenesis is still not well understood. In this study, progesterone levels in the female mud crab, Scylla paramamosain, were determined by enzyme-linked immunosorbent assay. Peak levels of progesterone were detected during the previtellogenic stage in the hemolymph, ovary, and hepatopancreas, whereas the progesterone level decreased significantly in vitellogenic stage I. During vitellogenic stage II, progesterone levels rose again in the hemolymph and ovary, but continued to decrease in the hepatopancreas. By using western blotting, progesterone receptor (PR), with an apparent molecular weight of 70 kDa, was identified in the ovary during both vitellogenic stages I and II. By means of immunohistochemistry, PR was detected mainly in the follicle cells during vitellogenic stage I and in the nuclei of oocytes in vitellogenic stage II. Our results strongly suggest that progesterone promotes vitellogenesis in the mud crab, S. paramamosain via a classical genomic mechanism.